BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1541065)

  • 1. Calcium mass transfer in peritoneal dialysis patients using 2.5 mEq/l calcium dialysate.
    Piraino B; Bernardini J; Holley J; Johnston JR; Perlmutter JA; Martis L
    Clin Nephrol; 1992 Jan; 37(1):48-51. PubMed ID: 1541065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium mass transfer with 10-hour dwell time using 1.25 versus 1.75 mmol/L calcium dialysate.
    Banalagay EE; Bernardini J; Piraino B
    Adv Perit Dial; 1993; 9():271-3. PubMed ID: 8105941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing 2.5 mEq/L calcium dialysate and calcitriol to 3.5 mEq/L calcium dialysate in patients on peritoneal dialysis.
    Banalagay E; Bernardini J; Holley J; Chen T; Piraino B
    Adv Perit Dial; 1993; 9():280-3. PubMed ID: 8105943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low calcium (2.5 mEq/l) and high calcium (3.5 mEq/l) dialysate in peritoneal dialysis patients.
    Wadhwa NK; Howell N; Suh H; Cabralda T
    Adv Perit Dial; 1992; 8():385-8. PubMed ID: 1361829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The requirement of low calcium dialysate in patients on continuous ambulatory peritoneal dialysis receiving calcium carbonate as a phosphate binder.
    Cheng IK; Lu HB; Chan CY; Cheng SW; Robinson JD; Tam SC; Lo WK; Cheung WC
    Clin Nephrol; 1993 Aug; 40(2):100-5. PubMed ID: 8222365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influencing factors in the control of phosphorus in peritoneal dialysis. Therapeutic options].
    Gallar P; Ortega O; Gutiérrez M; Muñoz M; Hilara L; Oliet A; Rodríguez I; Giménez E; Vigil A
    Nefrologia; 2000; 20(4):355-61. PubMed ID: 11039261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium carbonate is an effective phosphate binder when dialysate calcium concentration is adjusted to control hypercalcemia.
    Mactier RA; Van Stone J; Cox A; Van Stone M; Twardowski Z
    Clin Nephrol; 1987 Nov; 28(5):222-6. PubMed ID: 3427832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium mass transfer with dialysate containing 1.25 and 1.75 mmol/L calcium in peritoneal dialysis patients.
    Bender FH; Bernardini J; Piraino B
    Am J Kidney Dis; 1992 Oct; 20(4):367-71. PubMed ID: 1415205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dialysate calcium in continuous ambulatory peritoneal dialysis: a randomized controlled multicenter trial. The Peritoneal Dialysis Multicenter Study Group.
    Weinreich T; Passlick-Deetjen J; Ritz E
    Am J Kidney Dis; 1995 Mar; 25(3):452-60. PubMed ID: 7872324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group.
    Weinreich T; Ritz E; Passlick-Deetjen J
    Perit Dial Int; 1996; 16(3):260-8. PubMed ID: 8761540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAPD with low calcium dialysate and calcium carbonate: results of a 24-week study.
    Honkanen E; Kala AR; Grönhagen-Riska C; Ikäheimo R
    Adv Perit Dial; 1992; 8():356-61. PubMed ID: 1361822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful use of zero calcium dialysate to treat hypercalcemia in a postsurgical peritoneal dialysis patient.
    Mars RL
    Adv Perit Dial; 1993; 9():284-7. PubMed ID: 8105944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial.
    Basile C; Libutti P; Di Turo AL; Vernaglione L; Casucci F; Losurdo N; Teutonico A; Lomonte C
    Am J Kidney Dis; 2012 Jan; 59(1):92-101. PubMed ID: 22000728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of low calcium peritoneal dialysate.
    Kawanishi H; Tsuchiya T; Namba S; Takahashi N; Toyota T; Fukuma K; Kawai T
    ASAIO Trans; 1991; 37(3):M404-6. PubMed ID: 1751210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1993; 9():274-9. PubMed ID: 8105942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Satisfactory control of secondary hyperparathyroidism with low-calcium dialysate in patients not receiving vitamin D.
    Teruel JL; Nitvarro JF; Marcen R; Aguilera A; Tato A; Ottuño J
    Miner Electrolyte Metab; 1997; 23(1):19-24. PubMed ID: 9058365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Jimenez C; Del Peso G; Sanchez C; de Alvaro F
    Adv Perit Dial; 1996; 12():49-52. PubMed ID: 8865872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P; Olsen F; Heaf JG; Gammelgaard B; Pödenphant J
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium, magnesium mass transfer and lactate balance study in CAPD patients with reduced calcium/magnesium and high lactate dialysis fluid.
    Merchant MR; Hutchinson AJ; Butler SJ; Boulton H; Hintchliffe R; Gokal R
    Adv Perit Dial; 1992; 8():365-8. PubMed ID: 1361824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
    Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
    Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.